Press Releases | Longboard Pharmaceuticals

Skip to main navigation

Corporate Menu

About
Pipeline
Investors
Careers
Contact

Press Releases

Year

November 17, 2021

Longboard Pharmaceuticals Appoints Life Sciences Executive Dr. Jane Tiller to Board of Directors

November 11, 2021

Longboard Pharmaceuticals to Participate in Upcoming Investor Conferences

November 4, 2021

Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2021 Financial Results

November 2, 2021

Longboard Pharmaceuticals Announces Steven W. Spector Joins the Company as General Counsel

September 21, 2021

Longboard Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference on September 28, 2021

September 8, 2021

Longboard Pharmaceuticals Successfully Completes LP352 Multiple Ascending Dose Portion of Phase 1 Clinical Trial in Healthy Volunteers, Plans to Initiate Phase 1b/2a Clinical Trial

August 31, 2021

Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences

August 9, 2021

Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2021 Financial Results

May 10, 2021

Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2021 Financial Results

March 11, 2021

Longboard Pharmaceuticals Announces Pricing of Initial Public Offering

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 12

©2021 Longboard Pharmaceuticals Privacy Policy | Terms of Use

Corporate Menu

About
Pipeline
Investors
Careers
Contact